Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · IEX Real-Time Price · USD
2.260
-0.035 (-1.53%)
Jul 22, 2024, 11:18 AM EDT - Market open
Caribou Biosciences Employees
Caribou Biosciences had 158 employees as of December 31, 2023. The number of employees increased by 21 or 15.33% compared to the previous year.
Employees
158
Change (1Y)
21
Growth (1Y)
15.33%
Revenue / Employee
$211,418
Profits / Employee
-$729,494
Market Cap
201.41M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 158 | 21 | 15.33% |
| Dec 31, 2022 | 137 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| The Joint | 794 |
| bluebird bio | 323 |
| Biodesix | 217 |
| CVRx, Inc. | 200 |
| Century Therapeutics | 165 |
| Genfit | 159 |
| Shattuck Labs | 75 |
| Actinium Pharmaceuticals | 49 |
CRBU News
- 7 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caribou Biosciences, Inc. - CRBU - Accesswire
- 13 days ago - Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board - GlobeNewsWire
- 14 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caribou Biosciences, Inc. - CRBU - GlobeNewsWire
- 7 weeks ago - Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 7 weeks ago - Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 3 months ago - Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) - GlobeNewsWire
- 3 months ago - Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus - GlobeNewsWire